These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 695738)

  • 1. An electroaerosol device for group vaccination against influenza.
    Grinshpun L; Priimägi L; Subi K; Reinet J; Visnapuu L
    Z Erkr Atmungsorgane; 1978 Mar; 150(3):237-8. PubMed ID: 695738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination by the aerosol method.
    Priimägi L; Reinet J
    Z Erkr Atmungsorgane; 1978 Mar; 150(3):239-42. PubMed ID: 695739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effectiveness of large-scale vaccination against influenza in the USSR.
    Slepuskin AN; Bobyleva TK; Russina AE; Vitkina BS; Ellengorn NS; Zdanov VM
    Bull World Health Organ; 1967; 36(3):385-95. PubMed ID: 5299671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route.
    Petrescu A; Mihail A; Popescu A; Cojiţă M; Sternberg I; Steiner N; Hondor C
    Virologie; 1976; 27(1):41-5. PubMed ID: 941402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral influenza vaccination with live attenuated viruses. 1. Acceptability, immunogenicity and transmissibility.
    Petrilli FL; Crovari P; Cuneo-Crovari P; Badolati G; Canepa R
    Boll Ist Sieroter Milan; 1975 Oct; 54(4):312-22. PubMed ID: 1203087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients].
    Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J
    Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of neuraminidase monospecific (HEqN2) recombinant influenza vaccine in children.
    Beutner KR; Rizzone C; DeMello S; Ogra PL
    Dev Biol Stand; 1976; 33():162-70. PubMed ID: 782964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccination against influenza in children with acute lymphoblastic leukemia].
    Jackowska T; Brydak L; Rokicka-Milewska R; Lukowska K; Gosk B; Rudnicka H; Regnery H; Cox N
    Pediatr Pol; 1996 Apr; 71(4):301-6. PubMed ID: 8975216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response to hemagglutinin components of influenza vaccine in patients with non-Hodgkin malignant lymphoma.
    Brydak LB; Machała M; Centkowski P; Warzocha K; Biliński P
    Vaccine; 2006 Nov; 24(44-46):6620-3. PubMed ID: 16870313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural challenge of subjects vaccinated with WRL 105 strain live influenza vaccine in a residential community.
    Morris CA; Freestone DS; Stealey VM
    Dev Biol Stand; 1976; 33():197-201. PubMed ID: 782969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons.
    Szucs TD; Müller D
    Vaccine; 2005 Oct; 23(43):5055-63. PubMed ID: 16046035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
    Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine.
    Sonoguchi T
    Bull World Health Organ; 1969; 41(3):517-23. PubMed ID: 5309466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine].
    Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N
    Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of influenza vaccination: results in a community controlled for 2 years].
    Cuneo Crovari P; Gasparini R; Crovari P
    Boll Ist Sieroter Milan; 1980 Sep; 59(4):306-13. PubMed ID: 7470277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of influenza vaccination in healthy adults--a fourfold decrease in influenza morbidity during one influenza season].
    Chlíbek R; Beran J; Splino M
    Epidemiol Mikrobiol Imunol; 2002 Apr; 51(2):47-51. PubMed ID: 11987579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-scale field trial with neuraminidase vaccine.
    Vonka V; Závadová H; Brůj J; Skocil V; Janout V; Uvizl M; Kotíková J
    Dev Biol Stand; 1977 Jun 1-3; 39():337-9. PubMed ID: 342313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.